 WAYNE, Pa., Jan. 20, 2021 GLOBE NEWSWIRE -- Teleflex Incorporated NYSE: TFX announced today that new data published in the peer-reviewed journal, European Urology Focus , found that men treated with the Prostatic Urethral Lift PUL procedure using the UroLift System showed preservation and some improvement of sexual function compared to men being treated with medication for benign prostatic hyperplasia BPH. 